# PharmaEssentia Corporation, Taichung Plant – FDA Inspection, Apr 18, 2023

Source: https://www.keypedia.com/records/fda_inspections/pharmaessentia-corporation-taichung-plant/44ea154f-fa68-43b6-849b-faaf0187fdea
Source feed: FDA_Inspections

> FDA inspection 1204044 of PharmaEssentia Corporation, Taichung Plant, April 18, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204044
- Company Name: PharmaEssentia Corporation, Taichung Plant
- Inspection Date: 2023-04-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1224775 - 2023-09-21](https://www.keypedia.com/records/fda_inspections/pharmaessentia-corporation-taichung-plant/0d67fdcb-7fce-4257-8ece-10d9d69c73a0)

## Related Officers

- [Investigator](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)

Company: https://www.keypedia.com/companies/pharmaessentia-corporation-taichung-plant/97fafa0d-9006-45e0-a880-334c4e58248a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
